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Objective:  To establish whether an automated electronic tracker system for 
reporting of blood results would expedite clinician review of abnormal results in 
HIV positive out-patients and to pilot the use of this system in routine clinical 
practice 
 
Setting:  An out-patient service in central London providing specialist HIV 
related care to 3900 HIV positive patients  
 
Design:  A comparison of the time taken from sampling to identification and 
clinician review of abnormal blood results for biochemical tests between the 
original paper-based checking system and an automated electronic system 
during a three week pilot  
 
Results: Of 513 patients undergoing one or more blood tests, 296 (57.7%) had 
one or more biochemical abnormalities identified by the electronic checking 
system. 307/371 (83%) biochemical abnormalities were identified 
simultaneously by the paper-based system. Of the 307, 33 (10.7 %) were 
classified as urgent, 130 (42.3%) non-urgent and 144 (47%) as not clinically 
significant. The median interval between sampling to i) receipt of results was 1 
(IQ range 1-2) vs 4 days (IQR 3-5), p<0.0001; ii) clinician review 3 (IQR 1-4) vs 3 
days (IQR 3-6), p<0.037; and iii) review of non-urgent abnormalities by the 
regular clinician 2 (IQR 1-4) vs 10 days (IQR 9-12), P=0.136, for electronic and 
paper-based systems respectively. 7 (11%) of the missing paper-based system 
results were classified as urgent. The electronic system missed three 
abnormalities due to a software processing error which was subsequently 
corrected. 
 
Conclusions:  The electronic tracker system allows faster identification of 
biochemical abnormalities and allowed faster review of these results by 
clinicians.  The pilot study allowed for a software error to be identified and 
corrected prior to full implementation.  The system has since been integrated 
successfully into routine clinical practice. 
 
 
 
 
 
 
Introduction 
 
The numbers of individuals living with HIV in the United Kingdom continues to 
increase as a result of the benefits of antiretroviral therapy and continued high 
incident infection rates. It is estimated that the number of individuals living with 
HIV in the UK will exceed 100,000 by the end of 2012.1 
 
HIV can now be considered a chronic condition and patients can expect near 
normal life expectancies as a result of antiretroviral therapy.2 Many chronic 
conditions including HIV require frequent monitoring.  The British HIV 
Association guidelines for the routine investigation and monitoring of HIV-1-
infected adults (2011) outline which tests are required to assess the newly 
diagnosed individual and to monitor those on and off antiretroviral therapy.3  
HIV services face the challenge of regularly monitoring growing cohorts of 
patients and ensuring that clinically significant abnormalities are identified and 
acted upon promptly.   
 
Our service provides out-patient HIV related specialist care to 3900 HIV positive 
patients, all of whom require regular blood test monitoring.  Until the 
introduction of the electronic results checker we relied upon a manual paper-
based system to identify and flag abnormalities to clinicians.  On receipt of blood 
results at the clinic reception, these were sorted into normal and abnormal 
results by reception staff.  Abnormal results were reviewed by nursing staff to 
identify clinically significant abnormalities for review by the on-call doctor. The 
on-call doctor would then judge whether these abnormalities required urgent 
action or would pass on results to the patient’s regular clinic doctor for non-
urgent review. 
 
Several concerns about the paper-based system were identified including 
missing results, delayed delivery, clinician error and lack of an audit trail. These 
put patients at risk of serious clinical events such as drug toxicity and new 
infections.  A recent systematic review identified failure to follow up test results 
in acute hospital settings as a substantial problem and a critical safety issue.4 
Automatic alerting systems have been shown to improve efficiency and timely 
management of abnormal results in other heath care settings.5  
 
The importance of continuous quality improvement has become firmly 
embedded in NHS governance structure and organisational strategy6.  There is 
increasing recognition that all individuals with responsibility for healthcare 
delivery have a professional obligation to strive to improve the safety, clinical 
effectiveness and patients’ experience of their service7.  On identifying an aspect 
of local practice for which there is scope to improve performance for the benefit 
of patient care, the undertaking of a Quality Improvement Project affords a 
systematic approach to achieve tangible, practical and sustainable improvements 
in outcomes for patients.   
 
Having identified the shortcomings of our paper-based results reporting, we 
identified an electronic system (TA MonitorTM) with the potential to overcome 
these issues.  TA MonitorTM classifies results as normal, non-urgent and urgent 
according to pre-defined thresholds.  On logging into the checking system, the 
clinician is alerted to newly received laboratory abnormalities to dismiss, act 
upon or forward via email to the patient’s regular doctor.   We undertook our 
intervention within the QIPP (Quality, Innovation, Productivity and Prevention) 
framework8 with the intended quality improvement aim to identify and act upon 
abnormal results more promptly.  
 
Methods 
 
We conducted a study to compare the performance of the paper and electronic 
systems in identifying abnormalities.  The study also served to pilot the 
electronic system prior to implementation in routine clinical practice.  
 
For a three week period in July 2011 the electronic and paper systems were run 
in parallel to allow direct comparison of the time intervals from sampling to 
equivalent time-points for each system, namely: A) receipt of results, B) clinician 
(nursing staff) review of abnormalities, C) clinician (on-call doctor) review of 
abnormalities and D) review of non-urgent abnormalities by the regular clinician 
for both systems as shown in Figure 1 below. Owing to the large volumes of 
paper data generated, we restricted our pilot to a subset of common biochemical 
tests.  Abnormalities were reviewed daily by clinicians using the standard paper-
based system, but in addition these were classified as 1) urgent, 2) non-urgent or 
3) clinically non-significant according to pre-defined thresholds and graded 0-4 
according to the Division of AIDS table for the grading of severity of adult and 
paediatric adverse events9.  Clinic staff were asked to date and time stamp the 
paper results they reviewed to enable recording of the time period between 
blood sampling and review of results.  During the same three week period, 
abnormalities generated by the electronic system were reviewed daily by a 
designated clinician.  On logging into the system, the clinician is presented with 
those abnormal results which have been received since the previous login.  The 
clinician could then dismiss or act upon the abnormality, or forward the result to 
the regular clinician as appropriate. The time-points for the receipt of results and 
clinician review were recorded automatically by TA MonitorTM thus allowing 
comparison of equivalent time intervals with the paper-based system.  Urgent 
results were acted upon as soon as they were identified by either system.  Data 
was analysed using STATA V11.0.  Mann Whitney U tests were used to compare 
the intervals using both systems. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Comparison of receipt and review of abnormal results between the 
paper and electronic systems 
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Results 
 
Of 513 patients undergoing one or more blood tests, 296 (57.7%) had 
biochemical abnormalities identified by the electronic system as shown in Table 
1.  
 
 
Table 1:  Number of biochemical abnormalities 
 
Test Number Test Number 
Urea/Creatinine 24 Bilirubin 45 
Sodium 23 Alanine transaminase  23 
Potassium 12 Alkaline phosphatase 32 
Calcium 42 Lipids 172 
Phosphate 92 Urinary Protein 
Creatinine ratio 
14 
Glucose 14 Other 47 
 
 
307/371 (83%) biochemical abnormalities were identified simultaneously by 
the paper based system. Of the 307, 33 (10.7 %) were classified as urgent, 130 
(42.3%) non-urgent and 144 (47%) as not clinically significant. (Table 2)  Of the 
155 results classified by the Division of Aids grading table, 60 (39%) were grade 
1, 64 (41%) grade 2, 30 (19%) grade 3 and 1 (0.6%) grade 4 abnormalities.  
 
 
Table 2:  Number of biochemical abnormalities and time to receipt and 
review of results according to time interval and clinical significance for the 
electronic and paper systems 
 
Interval  Significance Electronic Median days 
(IQR) 
Paper Median days 
(IQR) 
A Urgent 33 1 (1-4) 33 4 (3-6) 
Non urgent 130 1 (1-2) 130 4 (3-5) 
Non 
significant 
144 1 (1-2) 143 4 (3-5) 
B Urgent 30 3 (1-4) 24 5 (4-6) 
Non urgent 123 3 (2-5) 66 5 (4-6) 
Non 
significant 
143 2 (1-3) 39 4 (3-5) 
C Urgent 30 3 (1-4) 18 4.5 (3-6) 
Non urgent 123 3 (2-4) 56 5 (3-6) 
Non 
significant 
143 2 (1-3) 27 3 (2-3) 
D Urgent 9 1 (1-7) 5 9 (9-11) 
Non urgent 19 2 (1-4) 15 11 (10-14) 
Non 
significant 
4 2 (1-3) 6 10.5 (10-11) 
 
 
7/64 (11%) of the missing paper results were classified urgent. The electronic 
system missed three abnormalities highlighting a software error which has now 
been corrected.  All results requiring action were acted upon as soon as they 
became available through either system. The median interval between sampling 
to each time point (A-D) is shown in graph 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 1:  The median number of days and interquartile range for intervals 
A-D following sampling for the electronic results checker (ERC) and paper-
based checker (PBC) 
 
 
 
Discussion 
 
Delays in the receipt of abnormal test results are a common source of frustration 
in clinical practice: one survey found that 83% of physicians reported reviewing 
at least one test result within the last two months that “they wished they had 
known about earlier”10 whilst an international survey of patients found that 8% 
in the UK had experienced delays in being notified about abnormal results.11  
Failure to follow up on abnormal test results in a timely fashion may have critical 
safety implications for patients4,12 alongside potential medico-legal 
consequences and a negative impact on patients’ experience of the service.  The 
adoption of the QIPP methodology provided us with a structured approach to 
address the shortcomings in our system by undertaking an intervention to 
improve the safety and experience of our patients. 
 
Biochemical abnormalities are common among our HIV cohort.  Compared to the 
paper based checking system, the electronic system was significantly faster in 
identifying laboratory abnormalities, facilitating timely management.  Given the 
high volume of tests performed, we anticipate that the electronic system will 
avoid delay/non-identification of a significant number of abnormal results 
within our service.   
 
The impact of faster clinician identification of laboratory abnormalities on our 
patients’ health outcomes is difficult to quantify and would require a larger 
cohort and prolonged follow-up which is beyond the scope of this pilot study.  
Nonetheless, the electronic system offers the additional benefit of a clear audit 
trail whereby in the event of an adverse clinical event, a written record is 
retained of when any laboratory abnormality was identified and by whom. 
 
Although our evaluation is limited by having examined biochemistry results 
alone we would anticipate similar reductions in reporting times for haematology 
and microbiology results. The number of abnormalities missed by the paper 
based system should be interpreted with caution as the failure for a result to be 
returned for audit does not always imply failure in receipt of the result and 
appropriate management.  The effectiveness of the paper based system may thus 
have been underestimated. 
 
The pilot showed that a high proportion (47%) of results identified as abnormal 
by the electronic system during the pilot were judged not to be clinically 
significant.  These included minor abnormalities in lipid profile and below-
normal levels of urea and creatinine requiring no action.  This finding prompted 
us to refine the thresholds for abnormalities identified by the tracker to reduce 
the quantity of unnecessary reviews by the attending clinician.  The checker 
software also allows refinement of thresholds at an individual patient level.  For 
example in a patient known to have chronic renal impairment, expected 
elevations in urea and creatinine at the patient’s baseline need not be repeatedly 
flagged up for review. 
 
Prior to piloting such a system it is essential to work with the software provider 
to ensure that all the required results are downloaded into the application, to 
pre-define the thresholds for urgent and non-urgent laboratory abnormalities 
and to establish a clear pathway for managing abnormal results. While the 
system is easy to use it is important to establish a training programme for 
existing and new staff with the support of an IT help desk to manage day-to-day 
operational issues. To ensure that abnormal results are identified promptly it is 
necessary to implement a system for the daily review of results by a designated 
clinician.  Where non-urgent abnormalities are forwarded by e-mail within the 
secure network it is important to have a system in place for when individuals are 
on leave. To overcome this we ensured that copies of these e-mails were also 
sent to the secretarial team so that results are forwarded to another clinician at 
times when the regular clinician is unavailable.  As an additional safeguard TA 
MonitorTM also produces a highlighted list of abnormal results that do not appear 
to have been reviewed by the regular clinician within a pre-specified period of 
time. It is important that the individual reviewing the daily results also reviews 
these to ensure they have been acted upon.   
 
 
Conclusions 
 
Our Quality Improvement Project has shown that adopting an automated system 
for identification of laboratory abnormalities in HIV positive out-patients leads 
to faster review of abnormal results by clinicians.  The electronic results checker 
has now been successfully introduced into routine clinical practice within our 
service with a duty rota in place to ensure that abnormal results are reviewed at 
least daily by a designated clinician.  We highlight the importance of piloting 
such systems concurrently with existing systems and safeguards to identify any 
processing errors and to troubleshoot use in practice prior to full 
implementation.  We advocate clinician engagement in the development and 
piloting of such software to facilitate subsequent ease of use, for example 
through modification of thresholds for reporting of abnormalities.  We anticipate 
that the sharing of our experience and methodology will be of use to those 
seeking to implement similar systems in the provision of HIV-related care, or in 
other clinical settings tasked with monitoring for laboratory abnormalities in 
large patient cohorts.   
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